These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy. Gonzalez-Rey E; Anderson P; Delgado M Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii70-6. PubMed ID: 17934101 [TBL] [Abstract][Full Text] [Related]
25. Is sudden infant death syndrome (SIDS) an autoimmune disorder of endogenous vasoactive neuropeptides? Staines DR Med Hypotheses; 2004; 62(5):653-7. PubMed ID: 15082084 [TBL] [Abstract][Full Text] [Related]
26. Is Gulf War Syndrome an autoimmune disorder of endogenous neuropeptides, exogenous sandfly maxadilan and molecular mimicry? Staines DR Med Hypotheses; 2004; 62(5):658-64. PubMed ID: 15082085 [TBL] [Abstract][Full Text] [Related]
27. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders. Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859 [TBL] [Abstract][Full Text] [Related]
28. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia. Delgado M; Jonakait GM; Ganea D Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366 [TBL] [Abstract][Full Text] [Related]
29. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Rabinovich GA; Liu FT; Hirashima M; Anderson A Scand J Immunol; 2007; 66(2-3):143-58. PubMed ID: 17635792 [TBL] [Abstract][Full Text] [Related]
30. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP. Ganea D; Delgado M Arch Immunol Ther Exp (Warsz); 2001; 49(2):101-10. PubMed ID: 11348014 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gonzalez-Rey E; Delgado M Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944 [TBL] [Abstract][Full Text] [Related]
33. Bidirectional regulatory circuit between the immune and neuroendocrine systems. Cavagnaro J; Lewis RM Year Immunol; 1989; 4():241-52. PubMed ID: 2467460 [TBL] [Abstract][Full Text] [Related]
34. Circadian rhythm and the immune response: a review. Habbal OA; Al-Jabri AA Int Rev Immunol; 2009; 28(1):93-108. PubMed ID: 19241255 [TBL] [Abstract][Full Text] [Related]
35. Leptin, from fat to inflammation: old questions and new insights. Otero M; Lago R; Lago F; Casanueva FF; Dieguez C; Gómez-Reino JJ; Gualillo O FEBS Lett; 2005 Jan; 579(2):295-301. PubMed ID: 15642335 [TBL] [Abstract][Full Text] [Related]
36. Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis. Gonzalez-Rey E; Delgado M Trends Mol Med; 2007 Jun; 13(6):241-51. PubMed ID: 17467339 [TBL] [Abstract][Full Text] [Related]
37. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells. Delgado M; Reduta A; Sharma V; Ganea D J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654 [TBL] [Abstract][Full Text] [Related]
38. Role of vasoactive intestinal peptide in inflammation and autoimmunity. Gonzalez-Rey E; Delgado M Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132 [TBL] [Abstract][Full Text] [Related]